Nazanin Nasehi graduated in Molecular and Cellular Biology from the University of Turin. She completed her master’s thesis at the Candiolo Cancer Institute, where she investigated the role of Neuroligin2 in pancreatic cancer progression. She later contributed to research at the Italian Institute of Technology in Milan, exploring light-based stimulation of skeletal muscle cells.
She is currently a research fellow in the Translational Genomic Unit at the Laboratory of Cancer Pharmacology at Humanitas Research Hospital, focusing on molecular characterization of stage I epithelial ovarian cancer.